Home/Filings/4/0000899243-21-001163
4//SEC Filing

Satter Muneer A 4

Accession 0000899243-21-001163

CIK 0001420565other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:15 PM ET

Size

7.0 KB

Accession

0000899243-21-001163

Insider Transaction Report

Form 4
Period: 2021-01-08
Transactions
  • Purchase

    Common Stock

    2021-01-08$1.10/sh+9,000,000$9,900,00016,609,449 total(indirect: See Footnote)
Footnotes (2)
  • [F1]Reflects shares that were purchased from the Issuer on January 8, 2021 in a registered direct offering pursuant to a Securities Purchase Agreement, dated January 6, 2021. The amount in Column 4 includes (a) 863,636 shares purchased by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares, (b) 863,636 shares purchased by various trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares and (c) 7,272,728 shares purchased by Satter Medical Technology Partners, L.P. ("SMTP") for which the Reporting Person has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clauses (b) and (c) of this footnote (1), except to the extent of his pecuniary interest therein.
  • [F2]The amount in Column 5 includes (a) 1,025,076 shares that are held by the Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares, (b) 1,231,044 shares that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares, and (c) the remaining balance of shares are held by SMTP for which the Reporting Person has sole voting and dispositive power over all such shares. The Reporting Person disclaims beneficial ownership of all shares included in clauses (b) and (c) of this footnote (2), except to the extent of his pecuniary interest therein.

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1
  • filerCIK 0001315797

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:15 PM ET
Size
7.0 KB